The structure ofPlasmodium yoeliimerozoite surface protein 119, antibody specificity and implications for malaria vaccine design
Open Access
- 1 January 2014
- journal article
- research article
- Published by The Royal Society in Open Biology
- Vol. 4 (1), 130091
- https://doi.org/10.1098/rsob.130091
Abstract
Merozoite surface protein 1 (MSP1) has been identified as a target antigen for protective immune responses against asexual blood stage malaria, but effective vaccines based on MSP1 have not been developed so far. We have modified the sequence of Plasmodium yoelii MSP119 (the C-terminal region of the molecule) and examined the ability of the variant proteins to bind protective monoclonal antibodies and to induce protection by immunization. In parallel, we examined the structure of the protein and the consequences of the amino acid changes. Naturally occurring sequence polymorphisms reduced the binding of individual protective antibodies, indicating that they contribute to immune evasion, but immunization with these variant proteins still provided protective immunity. One variant that resulted in the localized distortion of a loop close to the N-terminus of MSP119 almost completely ablated protection by immunization, indicating the importance of this region of MSP119 as a target for protective immunity and in vaccine development.Keywords
This publication has 46 references indexed in Scilit:
- Plasmodium falciparum 19-Kilodalton Merozoite Surface Protein 1 (MSP1)-Specific Antibodies That Interfere with Parasite GrowthIn VitroCan Inhibit MSP1 Processing, Merozoite Invasion, and Intracellular Parasite DevelopmentInfection and Immunity, 2012
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- A Field Trial to Assess a Blood-Stage Malaria VaccineThe New England Journal of Medicine, 2011
- Inhibition of Erythrocyte Invasion and Plasmodium falciparum Merozoite Surface Protein 1 Processing by Human Immunoglobulin G1 (IgG1) and IgG3 AntibodiesInfection and Immunity, 2009
- Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infectionMalaria Journal, 2009
- Comparative Testing of Six Antigen-Based Malaria Vaccine Candidates Directed Toward Merozoite-StagePlasmodium falciparumClinical and Vaccine Immunology, 2008
- Malaria Vaccine-Related Benefits of a Single Protein ComprisingPlasmodium falciparumApical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1Infection and Immunity, 2007
- The Most Polymorphic Residue on Plasmodium falciparum Apical Membrane Antigen 1 Determines Binding of an Invasion-Inhibitory AntibodyInfection and Immunity, 2006
- AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMRJournal of Biomolecular NMR, 1996
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995